• Home
  •  > Grant Detail
  • By Concept
  • By Last Name
  • By Full Text

 

Grant Detail

The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.



Human Airway Smooth Muscle Growth Regulation

Raymond B Penn

10 June 2001 - 31 May 2006
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Abstract

The long-range goal of this proposal is to identify the cellular and molecular signaling processes by which G protein-coupled receptors (GPCRs) modulate growth of human airway smooth muscle (ASM) cells. Numerous inflammatory and contractile agents known to activate GPCRs are elevated in the airways of patients with asthma, a disease characterized by airway hyperreactivity and increased ASM mass. The P.I.'s studies establish that despite the inability of most GPCR agonists to stimulate ASM growth by themselves, these agonists are capable of significantly increasing the proliferative effect of polypeptide growth factors. The mechanisms underlying this synergy between GPCR and receptor tyrosine kinase (RTK) activation are unknown. The central hypothesis of this proposal is that GPCRS and RTKs contribute distinct signals that can cooperate to activate p7Os6k and cause a synergistic induction of HASM growth. This hypothesis is supported by extensive preliminary data that demonstrate a prolonged, increased activation of p70s6k in ASM cells stimulated by RTK (EGF) and GPCR (thrombin, histamine, carbachol, and thromboxane) agonists. To test this hypothesis, we will examine the effects of specifically inhibiting molecules/pathways potentially upstream of p70s6k on: 1) p70s6k activity; 2) p70s6k phosphorylation; and 3) ASM growth that is stimulated by EGF, GCPR agonists, or both. In Aim 1, the role of GPCR-dependent transmembrane signaling events (specific heterotrimeric G protein activation, membrane-delineated scaffold formation) in p70s6k activation will be analyzed primarily using molecular biology techniques to inhibit heterotrimeric G protein-, arrestin-, and focal adhesion-dependent signaling. In Aim 2, we will target cytosolic molecules (calcium and phosphoinositides, focal adhesion kinases, Src, Akt, Akt, and PKC isoforms) in a similar manner to examine their roles in increased p70s6k activation. In Aim 3, mutants of p70s6k will be expressed in ASM cultures for the purpose of analyzing the relative contributions of EGF and GPCR agonists in the phosphorylation of specific amino acids of p70s6k. In Aim 4, molecules/pathways shown to mediate the GPCR-dependent modulation p70s6k activation will be inhibited in assays of RTK+GPCR-dependent cell growth. Collectively these studies will clarify the role of GPCRS as transducers of growth signaling, enhance our understanding of an important growth-regulatory molecule, and identify potential targets for therapeutic management of asthma.

6 Resulting Publications

Scientific Context

This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.

Related Grants

Related Publications